Cogent Biosciences Inc (NASDAQ:COGT) currently has a daily average trading volume of 1.52M but it saw 2001390 shares traded in last market. With a market cap of 898.05M USD, the company’s current market price of $8.13 came rising about 0.12 while comparing to the previous closing price of $8.12. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.61 and as low as $4.28. In the recent trading on the day, stock has struck highest price mark of $8.01 while lowest mark touched by it was $8.44.
Taking a look at 20-day trading activity of Cogent Biosciences Inc (COGT) gives us an average price of $7.87, while its current price level is -35.53% below from 52-week high level whereas it is 89.95% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $8.84 while that of 200 days or SMA-200 reads an average of $9.06. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.36% during that period while stretching the period over a month that decreases to 6.64%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 48.22 which implies that the stock is in neutral territory.
Robert W. Baird downgraded its recommendation for the stock as a “Neutral” from “Outperform” on February 26, 2024 while assigning a price target range of $14-$8. Citigroup issued its recommendations for the stock as it initiated the price target for the stock is $11.
Over the week, COGT’s stock price is moving 0.25% up while it is -0.25% when we observe its performance for the past one month. Year-to-date it is 4.23% up and over the past year, the stock is showing an upside performance of 72.25%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of -0.57 while estimate for next year EPS is -2.32.
Currently, Cogent Biosciences Inc’s total number of outstanding shares is 110.46M with 0.12% of that held by the insiders while 111.19% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -73.21% and return on equity (ROE) at -78.47%. Stock’s beta reads 1.76. Stock has a price to book (P/B) ratio of 4.40. Its return on asset (ROA) is -65.53% on average.
